Rheumatoid Arthritis
Showing NaN - NaN of 178
Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)
Recruiting
- Rheumatoid Arthritis
- ATI-450 50mg oral tablet BID
- +3 more
-
El Cajon, California
- +24 more
Jan 27, 2023
Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)
Completed
- Rheumatoid Arthritis
-
Little Rock, Arkansas
- +133 more
Jan 26, 2023
Rheumatoid Arthritis Trial in United States (procedure, drug, device)
Recruiting
- Rheumatoid Arthritis
- Implant Procedure
- +3 more
-
Birmingham, Alabama
- +33 more
Jan 3, 2023
Rheumatoid Arthritis Trial in Canada, United States (ISIS 104838)
Completed
- Rheumatoid Arthritis
- ISIS 104838
-
Birmingham, Alabama
- +30 more
Dec 1, 2022
Rheumatoid Arthritis Trial in Worldwide (Filgotinib, Placebo to match filgotinib)
Active, not recruiting
- Rheumatoid Arthritis
- Filgotinib
- Placebo to match filgotinib
-
Huntsville, Alabama
- +344 more
Oct 20, 2022
Rheumatoid Arthritis Trial in United States (Lovastatin, Placebo)
Rheumatoid Arthritis Trial in United States (Certolizumab pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab pegol
-
Covina, California
- +8 more
Jul 26, 2022
Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))
Completed
- Rheumatoid Arthritis
- Upadacitinib
- Pneumococcal 13-valent conjugate vaccine (PCV-13)
-
Huntsville, Alabama
- +123 more
Jun 15, 2022
Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)
Active, not recruiting
- Rheumatoid Arthritis
- Placebo for Adalimumab
- +3 more
-
Birmingham, Alabama
- +369 more
Jun 14, 2022
Systemic Lupus Erythematosus, Rheumatoid Arthritis Trial in United States (PF-06835375, Placebo)
Completed
- Systemic Lupus Erythematosus
- Rheumatoid Arthritis
- PF-06835375
- Placebo
-
Anniston, Alabama
- +17 more
Apr 6, 2022
Rheumatoid Arthritis Trial in United States (Experimental: Arm A: DRL_RI, Arm B: Rituxan®/Mabthera®)
Active, not recruiting
- Rheumatoid Arthritis
- Experimental: Arm A: DRL_RI
- Arm B: Rituxan®/Mabthera®
-
Phoenix, Arizona
- +25 more
Apr 6, 2022
Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)
Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))
Completed
- Rheumatoid Arthritis
- SAR153191 (REGN88)
-
Anniston, Alabama
- +334 more
Mar 21, 2022
Rheumatoid Arthritis Trial in United States (Tc99m tilmanocept)
Active, not recruiting
- Rheumatoid Arthritis
- Tc99m tilmanocept
-
Miami Lakes, Florida
- +6 more
Mar 21, 2022
Rheumatoid Arthritis Trial in Worldwide (BMS-945429 Placebo, BMS-945429, Methotrexate)
Completed
- Rheumatoid Arthritis
- BMS-945429 Placebo
- +5 more
-
Peoria, Arizona
- +99 more
Dec 3, 2021
Rheumatoid Arthritis, Inflammatory Arthritis, Arthritis Trial in United States (Herpes Zoster (HZ) Vaccine, Placebo)
Completed
- Rheumatoid Arthritis
- +7 more
- Herpes Zoster (HZ) Vaccine
- Placebo
-
Birmingham, Alabama
- +33 more
Oct 23, 2021
Rheumatoid Arthritis Trial in Germany, United States (AMG 570, Placebo)
Completed
- Rheumatoid Arthritis
- AMG 570
- Placebo
-
Anniston, Alabama
- +3 more
Oct 7, 2021